PHARMACY

Galderma releases Epsolay
The topical cream is for the treatment of bumps and blemishes (inflammatory lesions) of rosacea in adults.
Accord launches generic Alimta
Pemetrexed Lyo. Injection is used to treat non-squamous non-small cell lung cancer and malignant pleural mesothelioma, a cancer of the inside lining of the chest cavity.

Aetna Better Health of Kansas donates $125K to support Kansas communities

The donations will support healthcare providers and help the community meet health and social care needs, such as those related to mental health, developmental disabilities and housing.
APhA changes executive leadership

Ilisa Bernstein has been appointed interim CEO of APhA, succeeding Scott Knoer.
AllianceRx Walgreens Prime, Walgreens study adherence in cystic fibrosis, ulcerative colitis/crohn’s disease patients

Specialty pharmacy interventions focused on adherence may improve patient outcomes, according to findings of two studies.
Cardinal Health to open distribution center in Central Ohio

The 208,144-sq.-ft. building will be the 10th U.S. distribution center for Cardinal Health at-Home Solutions.
APhA survey: Majority of pharmacists are prepared to administer COVID-19 shot to kids under 5

Sixty-six percent of pharmacists would be prepared to administer COVID-19 vaccines to children under 5 years old if authorized to do so.
FDA approves Roche’s Evrysdi for use in babies under 2 months old with SMA

Evrysdi is designed to treat SMA by increasing and sustaining the production of the survival motor neuron protein in the central nervous system and peripheral tissues.
Dr. Reddy's intros generic Alimta

The Alimta brand and generic had a market value of approximately $1.2 billion for the most recent 12 months ending in March 2022, according to IQVIA.
FDA grants Servier approval for new indication of Tibsovo

Tibsovo is the first therapy targeting cancer metabolism approved in combination with azacitidine for patients with newly diagnosed IDH1-mutated acute myeloid leukemia.